ETERNAL: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle

ETERNAL：促进减少药品整个生命周期对环境的影响

• 批准号: 10039220
• 金额: $ 43.9万
• 依托单位: UK CENTRE FOR ECOLOGY AND HYDROLOGY
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10039220
• 关键词: ETERNAL; Boosting; reduction; environmental; impact

ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only the API and residues/metabolites, but other chemicals and by-products of the production process. This type of approach is essential to take into consideration the types of green manufacturing approach under consideration by the pharmaceutical industry, as evidenced by the range and scope of case studies being undertaken within ETERNAL. Specific application of our risk and life cycle assessment approaches to the ETERNAL case studies is a key element of the proposed work and will provide industry and policymakers with key examples of how whole life cycle assessment may be used to evaluate the changes in environmental impacts expected due to the introduction of green manufacturing processes.

ETERNAL旨在通过使用和推广涵盖设计、制造、使用和处置的全生命周期方法，不仅评估原料药和残留物/代谢物的环境风险，还评估生产过程中的其他化学品和副产品，从而促进药品生产、使用和处置的可持续发展。这种类型的方法对于考虑到制药行业正在考虑的绿色制造方法的类型至关重要，正如在ETERNAL中进行的案例研究的范围和范围所证明的那样。我们的风险和生命周期评估方法在ETERNAL案例研究中的具体应用是拟议工作的一个关键要素，并将为行业和政策制定者提供关键示例，说明如何使用全生命周期评估来评估由于引入绿色制造过程而预期的环境影响变化。